Farallon Capital Management Llc

Source: SEC Form 13F · as of Mar 2026

Farallon Capital Management Llc holds 94 biotech & pharma companies tracked by BioSniper, totaling $6.44B in value as of Mar 2026 (SEC Form 13F).

Companies held

94

Total value held

$6.44B

CompanySharesValue
RVMDREVOLUTION MEDICINES, INC.13,604,796$1.32B
BBIOBridgeBio Pharma, Inc.9,365,463$695.5M
PTGXProtagonist Therapeutics, Inc6,348,906$669.2M
UNHUnitedHealth Group Incorporated Common Stock (DE)1,821,706$492.9M
LNTHLantheus Holdings, Inc.5,583,479$423.5M
LQDALiquidia Corp8,656,038$326.7M
CRNXCrinetics Pharmaceuticals, Inc.8,338,098$302.8M
ROIVRoivant Sciences Ltd.9,675,000$268.0M
BEAMBeam Therapeutics Inc.10,134,696$241.5M
MCKMcKesson Corporation234,300$202.8M
AGIOAGIOS PHARMACEUTICALS, INC.5,684,000$192.3M
CNTACentessa Pharmaceuticals plc4,809,000$191.0M
TNGXTango Therapeutics, Inc.9,097,411$190.3M
TYRATyra Biosciences, Inc.3,580,818$137.1M
CAHCardinal Health Inc.368,000$77.8M
PCVXVaxcyte, Inc.1,261,000$73.3M
DNTHDianthus Therapeutics, Inc. /DE/836,000$70.2M
TWSTTwist Bioscience Corp1,427,650$67.8M
CGONCG Oncology, Inc.674,000$45.6M
AZNASTRAZENECA PLC226,499$44.7M
MRKMerck & Co., Inc.361,000$43.4M
ACHCAcadia Healthcare Company Inc.1,736,800$40.6M
IMVTImmunovant, Inc.1,546,000$38.4M
ENTAENANTA PHARMACEUTICALS INC2,871,862$36.3M
JNJJOHNSON & JOHNSON148,000$36.2M
BBNXBeta Bionics Inc.3,607,920$36.2M
ASMBASSEMBLY BIOSCIENCES, INC.1,227,590$34.1M
NVONovo Nordisk A/S782,000$28.7M
RPRXRoyalty Pharma plc493,000$23.6M
NERVMinerva Neurosciences, Inc.2,365,000$14.2M
AVTXAvalo Therapeutics, Inc.916,000$13.7M
MAZEMaze Therapeutics, Inc.373,000$11.1M
TEVATeva Pharmaceutical Industries Limited354,000$10.7M
RNAAtrium Therapeutics Inc.349,360$4.7M
MOHMolina Healthcare Inc35,000$4.7M
IRDOpus Genetics, Inc.1,000,000$4.5M
PRMEPrime Medicine, Inc.1,240,843$4.3M
MDGLMADRIGAL PHARMACEUTICALS, INC.3,319$1.7M
CAPRCAPRICOR THERAPEUTICS, INC.41,000$1.2M
ARWRARROWHEAD PHARMACEUTICALS, INC.15,800$991K
GHGuardant Health Inc.8,000$739K
ALKSAlkermes plc.20,800$735K
ALVOAlvotech199,675$685K
AXSMAxsome Therapeutics, Inc.4,000$676K
COGTCogent Biosciences, Inc.17,000$654K
ARQTArcutis Biotherapeutics, Inc.26,000$613K
TERNTerns Pharmaceuticals, Inc.7,000$369K
IONSIONIS PHARMACEUTICALS INC4,800$360K
TVTXTravere Therapeutics, Inc.12,000$357K
GMEDGlobus Medical Inc.4,000$345K
SRRKScholar Rock Holding Corp7,000$344K
ONCBeOne Medicines Ltd.1,100$327K
CORCencora Inc.1,000$314K
NUVLNuvalent, Inc.3,000$307K
PGNYProgyny Inc.18,000$306K
STOKStoke Therapeutics, Inc.9,000$293K
ERASErasca, Inc.18,000$291K
NKTRNEKTAR THERAPEUTICS4,000$288K
MIRMMirum Pharmaceuticals, Inc.3,000$277K
KRYSKrystal Biotech, Inc.1,000$258K
OMEROMEROS CORP23,000$243K
ALMSALUMIS INC.11,000$242K
APLSApellis Pharmaceuticals, Inc.6,000$241K
SNDXSyndax Pharmaceuticals Inc10,000$234K
FOLDAMICUS THERAPEUTICS, INC.16,000$231K
QUREuniQure N.V.14,000$229K
BCRXBIOCRYST PHARMACEUTICALS INC24,000$228K
GRFSGrifols S.A.28,000$225K
ABVXAbivax SA2,000$223K
GEHCGE HealthCare Technologies Inc.3,000$214K
BLTEBELITE BIO, INC1,300$207K
MMSIMerit Medical Systems Inc.3,000$207K
SUPNSUPERNUS PHARMACEUTICALS, INC.4,000$207K
URGNUroGen Pharma Ltd.11,000$198K
VIRVir Biotechnology, Inc.22,000$197K
PGENPRECIGEN, INC.50,000$194K
SDGRSchrodinger, Inc.17,000$193K
DYNDyne Therapeutics, Inc.10,000$181K
NVAXNOVAVAX INC22,000$179K
SLSSELLAS Life Sciences Group, Inc.40,000$169K
ADPTAdaptive Biotechnologies Corp11,000$153K
OCULOCULAR THERAPEUTIX, INC18,000$152K
NEONeoGenomics Inc.19,000$141K
ARDXARDELYX, INC.23,000$138K
OSCROscar Health Inc.11,000$126K
NUVBNuvation Bio Inc.29,000$124K
IOVAIOVANCE BIOTHERAPEUTICS, INC.26,000$91K
ALTAltimmune, Inc.27,600$85K
CCCCC4 Therapeutics, Inc.28,000$74K
TVRDTvardi Therapeutics, Inc.21,438$68K
GERNGERON CORP43,000$64K
RANIRani Therapeutics Holdings, Inc.78,000$57K
IRWDIRONWOOD PHARMACEUTICALS INC13,000$46K
CGCCanopy Growth Corp30,000$28K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Farallon Capital Management Llc — Biotech 13F Holdings & Portfolio | BioSniper